Charles Stanley sees revenues drop amid 'difficult times'

CEO says business remains resilient

Anna Fedorova
clock • 1 min read

Charles Stanley Group has seen its group revenue drop 6.8% in Q3 2020 compared to the previous quarter, though funds under management and administration (FuMA) increased 0.9% to stand at £22.8bn.

Over the six months to 30 September, total FuMA shot up 12.9%, but the group said this was a reflection of the turbulent markets caused by the coronavirus pandemic. In fact, average FuMA during the six-month period dropped 9.4% compared to the average of £24.4bn during the same period last year. Meanwhile, though group revenue dropped over both three and six months, the group said it outperformed relative to average FuMA as a result of "an improved revenue margin, which increased by 4.4bps to 74.3bps". This was the result of an increase of discretionary funds as a proportion of tot...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Advisers zoomed in on capital accumulation in Q4 2025

Advisers zoomed in on capital accumulation in Q4 2025

Titan Square Mile research finds

Jen Frost
clock 30 January 2026 • 3 min read
Measure for measure: How to track your tracker fund

Measure for measure: How to track your tracker fund

Tracking difference and tracking error

Terry McGivern
clock 28 January 2026 • 3 min read
SJP and AJ Bell pivot from US mega-caps in MPS as concentration woes continue

SJP and AJ Bell pivot from US mega-caps in MPS as concentration woes continue

Healthcare, energy and EM preferred

Linus Uhlig
clock 28 January 2026 • 2 min read